The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2025 | Increasing equity in lung screening in high-risk populations
David Baldwin, MD, FRCP, Nottingham City Hospital, Nottingham, United Kingdom, comments on the challenges and opportunities of improving lung cancer screening in high-risk populations, particularly those from socioeconomically disadvantaged groups. There is a need to address the low participation rates in these groups, but tailored approaches may not be as effective as using primary care doctor invitations and reminders, as seen in the Lung Screen Uptake Trial (Lung-SCREEN) (NCT02558101). However, novel screening programs has shown remarkable effects on equity, with a shift in the socio-demographic profile of lung cancer diagnoses, reducing socioeconomic inequity. This interview took place at the European Lung Cancer Congress (ELCC) 2025 in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
